And actually, when doing a quick history search of this board, it looks like it has been mostly ewan_trades (another alias of adamisamoron) who has been pretending to have a finance degree.
This is rather amusing because the ewan_trades aliases often display humorous ignorance of basic principles of investing and macroeconomics and they tend dabble in goldbug conspiracy theory type thinking..
"ewan_trades_2 • Nov 9, 2010 2:08 PM Flag
You two aren't bright enough to understand an economic discussion on inflation. I actually have a Finance degree and an MBA. I understand government manipulation of indices. It is deception and they have been changing them over the years. They do it so as to keep the cost of living increases of Social Security etc down, they do it to artificially keep interest rates down because if they go up they can't pay the interest on the existing government debt, etc. Oh yes they do it to give dumb dumbs like you, and unfortunately there are a lot of dumb dumbs around, additional coolaid so you think that there really isn't any inflation. Go check out the price of wheat, corn, gold, silver, metals in general."
You must be confused. I do not have a finance degree and have never claimed to have one.
Perhaps you are confused about another stock message board that you also use to pump other garbage stocks?
Anyway, I think that it is only natural to be disappointed that the snake oil salesman gets to slip away before the end.
In fact, if you find yourself delighted that Carter was able to make cash-strapped HEB pay him an extra $750K as he left the door, it is hard to believe that you are any true friend of the genuine and long-beleaguered retail investors of HEB.
It's been obvious for a while that HEB is doomed, and the boiler room pumping won't be able to keep it going much longer.
I'm just find it disappointing that Carter is a rat who was able to leave this sinking ship and charge HEB a $750K fee for doing so.
HEB torched its credibility with that second bogus NDA submission.
I am just an observer of HEB who has come to be revolted by the boiler room promotions of this garbage company that have been going on ever since it was brought public by Stratton Oakmont.
While the pumpers on this board are sometimes unintentionally humorous with their ignorant postings, overall I find them quite disgusting as their goal is to try to lure in naive and innocent investors into buying shares of this awful company.
"Due to the repair issues mentioned above within our NJ facility and the high cost estimates to bring the facility back online, we most likely will need additional funds to finance the revalidation process in our facility to initiate commercial manufacturing, thereby readying ourselves for an FDA Pre-Approval Inspection."
Such a pity...
The 10-Q is coming out soon, and it may have devastatingly bad news.
Be sure to protect yourself by having a stop-loss order in place for HEB beforehand!
The FDA found alarming discrepancies in the Ampligen safety data that HEB submitted, which cast grave doubts about HEB's honesty.
"The safety assessment of Ampligen revealed a number of discrepancies in the sponsor’s data. Key issues include some serious adverse events not counted by the sponsor, marked laboratory abnormalities that were not reported in the database, miscoding of adverse events and reasons for discontinuation, lack of adverse event definitions, and misleading or incomplete presentations of data. These discrepancies raise significant questions about data from all of the trials and whether or not the data are sufficient to determine the safety profile of Ampligen."
Many ADCOM reviewers cited doubts about HEB's veracity when asked for the reasons for their "NO" votes:
"DR. BUCKLEY: So we’ll go around the room again, starting with Dr. Hennessy, stating your name, your vote, reason for vote, or any comments about future studies.
DR. HENNESSY: Sure. Sean Hennessy. I voted no. I don’t believe that the size or veracity of the safety database is adequate.
DR. KOMAROFF: Komaroff. I agree completely. Neither the size nor, more importantly, the veracity of the data presented is persuasive.
DR. GARDNER: Gardner. I voted no, for the same reason.
DR. WARE: WARE. I voted no, for those reasons, also.
DR. D’AGOSTINO: D’Agostino. I voted no for those reasons."
By submitting false or misleading safety data, HEB may have burned its bridges with the FDA.
NK-Cells are a very unreliable marker that can be affected by too many other conditions to be useful.
As the Institute of Medicine reported:
"Low NK cytotoxicity is not specific to ME/CFS. It is also reported to be present in patients with rheumatoid arthritis, cancer, and endometriosis (Meeus et al., 2009; Oosterlynck et al., 1991; Richter et al., 2010). It is present as well in healthy individuals who are older, smokers, psychologically stressed, depressed, physically deconditioned, or sleep deprived "
A test that cannot distinguish between CFS and "healthy individuals who are older, smokers, psychologically stressed, depressed, physically deconditioned, or sleep deprived" is a pretty worthless test.
Twelve weeks of GE and IE training significantly improved CD4 lymphocyte activation and aerobic capacity without exacerbating CFS symptoms. IE may be a more effective exercise modality with regard to enhanced CD4 activation in CFS patients.
PMID: 27116645 [PubMed - as supplied by publisher]
Med Sci Sports Exerc. 2016 Apr 26.
Graded vs Intermittent Exercise Effects on Lymphocytes in Chronic Fatigue Syndrome.
Broadbent S1, Coutts R.
There is increasing evidence of immune system dysfunction in Chronic Fatigue Syndrome (CFS) but little is known of the regular exercise effects on immune cell parameters. This pilot study investigated the effects of graded and intermittent exercise on CD4 lymphocyte subset counts and activation compared to usual care.
24 CFS patients (50.2 ± 10 yr) were randomised to Graded exercise (GE), Intermittent exercise (IE) or usual care (UC) groups; 18 sedentary non-CFS participants (50.6 ± 10 yr) were controls (CTL) for blood and immunological comparisons. Outcome measures were pre- and post-intervention flow cytometric analyses of circulating lymphocyte subset cell counts, expression of CD3, CD4, CD25 and CD134, full blood counts and V[Combining Dot Above]O2peak RESULTS: Pre-intervention, CD3 cell counts and expression of CD4, CD25, CD134 and CD4CD25CD134 were significantly lower in GE, IE and UC compared to CTL (f
No one trusts the veracity of HEB or of HEB's paid pumpers.
"Total Prescriptions Market Share
TOTAL MARKET 1,623,092; 100.0%
Aldara (imiquimod) 1,194,224; 73.6%
Carac (flurouracil) 229,905; 14.2%
Efudex (flurouracil)173,308; 10.7%
Intron A (interferon alfa-2b) 12,710;0.8%
Fluoroplex (flurouracil) 12,467; 0.8%
Alferon N (interferon alfa-n3) 478; 0.0%"
In Alferon's best year, they sold 478 prescriptions and captured 0.0% of the market.
And in their 10-K they write:
"In light of these contingencies, there can be no assurances that the approved Alferon N Injection® product will be returned to production on a timely basis, if at all, or that if and when it is again made commercially available, it will return to prior sales levels."
Gosh, they may not ever get back to 0.0% ? How sad....
"any failed treatment"
funny, but that phrase does not appear in the package insert.
Hebpumper needs to study this timeline harder. He seems very confused about the dates when Alferon was approved and received its labeling and when Intron A was approved. He should study the rest of this timeline as well to help protect himself from looking so foolish in his Alferon pumps.
I still don't think that it has sunk into hebpumper's mind that Intron A came out nearly a decade after that package insert came out. Didn't someone here recently post a timeline for alpha-interferons?
"why you didnt include the words just before that. the words you chose....."
Because those words were not at all pertinent to explaining what they were referring to when they spoke of refractory treatment, but are just general language about how physicians should consider the size and location of the warts when deciding treatment.
Again, hebpumper's poor literacy skills can be very tedious.